Join AlphaMaven

The Home Of Alternative Investments

Register For Free Learn More Create Investment Listing

Most Visited Alternative Investment Industry Website. Over 50,000 visitors per month

Alternative Investment Posts

Andrea Alms Video:  Money In Motion 162 - Revenue Models Of The AI Drug Development Process Part 1
Private Equity BrookDell Partners Views: 1

Andrea Alms Video: Money in Motion 162 - Revenue Models of the AI Drug Development Process Part 1

TRANSCRIPT Hello, my name is Andrea Alms I'm technology investor and financial manager and this is your money in motion. What is the revenue model for AI development? AI development is a multi-stakeholder process for early stage AI startups. It is imperative they work with relatively large and established companies. Here are four general models describing these partnerships in the order of i


Member Posts:

Most popular| Most recent
Bensboro Seasonal Spread Trading Program - AlphaMaven Performance Report
Managed Futures Bensboro Seasonal Spread Trading Program #Investment Update
AlphaMaven Crypto Traders Index
Crypto AlphaMaven Crypto Traders Index #Investment Update
Bensboro Seasonal Futures Fund, L.P. - Performance Report
Managed Futures Bensboro Seasonal Futures Fund, L.P. #Investment Update
Crystal Bay Ubitrend - AlphaMaven Performance Update
Managed Futures Crystal Bay Ubitrend #Investment Update
CTA Strats - CTA Trend II (Diversified) - AlphaMaven Performance Report
Managed Futures CTA Strats - CTA Trend II (Diversified) #Investment Update
Jamarant Capital, LP - AlphaMaven Performance Report
Hedge Fund Jamarant Capital, LP #Investment Update
Millstreet Credit Fund LP - AlphaMaven Performance Report
Hedge Fund Millstreet Credit Fund LP #Investment Update
Adalpha Diversified Short-Term Program - AlphaMaven Performance Report
Managed Futures Adalpha Diversified Short-Term Program #Investment Update
Kensington Private Equity Fund - AlphaMaven Performance Report
Private Equity Kensington Private Equity Fund #Investment Update
Adalpha Medium-Term Program - AlphaMaven Performance Report
Managed Futures Adalpha Medium-Term Program #Investment Update
Adalpha Core Program - AlphaMaven Performance Report
Managed Futures Adalpha Core Program #Investment Update
Emerald Bay Equity Strategy - AlphaMaven Performance Report
Hedge Fund Emerald Bay Equity Strategy #Investment Update
CTA Strats - CTA Trend I (FX Only) - AlphaMaven Performance Report
Managed Futures CTA Strats - CTA Trend I (FX Only) #Investment Update
CTA Strats - Trend III (CFDs And Spot FX) - AlphaMaven Performance Report
Managed Futures CTA Strats - Trend III (CFDs & Spot FX) #Investment Update
Seven UCITS - Seven Force 5 - I Share AlphaMaven Performance Report
Hedge Fund Seven UCITS - Seven Force 5 - I Share #Investment Update
Seven European Equity Fund (EUR) - AlphaMaven Performance Report
Hedge Fund Seven UCITS - Seven European Equity Fund (EUR) #Investment Update
Seven UCITS - Seven Force 2 (I Shares) - AlphaMaven Performance Report
Hedge Fund Seven UCITS - Seven Force 2 - I Shares #Investment Update
Seven Absolute Return Program - AlphaMaven Performance Report
Hedge Fund Seven Absolute Return Program #Investment Update
Arion Oil Products Trading - AlphaMaven Performance Report
Managed Futures Arion Alpha Strategies SPC - Arion Oil Products Trading SP #Investment Update
Pier Music Royalties Fund LP - AlphaMaven Performance Report
Hedge Fund Pier Music Royalties Fund LP #Investment Update
FREE NEWSLETTER (140K+ Subscribers)
View Member Posts Listings
SPONSORED BY
Be Seen - Advertise With Us
Click to Discuss
FEATURED MEMBER POSTS
DLD Master Fund Investor Presentation - May 2025
- posted by: DLD Master Fund
Andrea Alms Video:  Money In Motion 162 - Revenue Models Of The AI Drug Development Process Part 1
- posted by: BrookDell Partners
Andrea Alms Video:  Money In Motion 160 - Pharma Q1 2025 Revenue Decline
- posted by: BrookDell Partners
Exome Asset Management's Worldwide Healthcare Partners Fund Posts Its May 2025 Results
- posted by: Worldwide Healthcare Partners
Andrea Alms Video:  Money In Motion 161 - AI Drug Development Market
- posted by: BrookDell Partners
Andrea Alms Video:  Money In Motion 163 -Revenue Models Of The AI Drug Development Process Part 2
- posted by: BrookDell Partners
Exome Asset Management's Emerging Markets Healthcare Partners Fund Posts Its May 2025 Results
- posted by: Emerging Markets Healthcare Partners Strategy
Andrea Alms Video:  Money In Motion 159 - Bitcoin Energy Mining
- posted by: BrookDell Partners
DLD Master Fund Posts Its May 2025 Performance
- posted by: DLD Master Fund
Log In for More
Access Over 250K+ Industry Headlines, Posts and Updates

Subscribe to our FREE DAILY newsletter

Please Select Industry Primary Role*
Not a member yet?

Join AlphaMaven

The Premier Alternative Investment
Research and Due Diligence Platform for Investors

Free Membership for Qualified Investors and Industry Participants
  • Easily Customize Content to Match Your Investment Preferences
  • Breaking News 24/7/365
  • Daily Newsletter & Indices
  • Alternative Investment Listings & LeaderBoards
  • Industry Research, Due Diligence, Videos, Webinars, Events, Press Releases, Market Commentary, Newsletters, Fact Sheets, Presentations, Investment Mandates, Video PitchBooks & More!
  • Company Directory
  • Contact Directory
  • Member Posts & Publications
  • Alpha University Video Series to Expand Investor Knowledge
  • AUM Accelerator Program (designed for investment managers)
  • Over 450K+ Industry Headlines, Posts and Updates
Sign Up Now
ALL ALPHAMAVEN CONTENT IS FOR INFORMATIONAL PURPOSES ONLY. CONTENT POSTED BY MEMBERS DOES NOT NECESSARILY REFLECT THE OPINION OR BELIEFS OF ALPHAMAVEN AND HAS NOT ALWAYS BEEN INDEPENDENTLY VERIFIED BY ALPHAMAVEN. PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS. THIS IS NOT A SOLICITATION FOR INVESTMENT. THE MATERIAL PROVIDED HEREIN IS FOR INFORMATIONAL PURPOSES ONLY. IT DOES NOT CONSTITUTE AN OFFER TO SELL OR A SOLICITATION OF AN OFFER TO BUY ANY INTERESTS OF ANY FUND OR ANY OTHER SECURITIES. ANY SUCH OFFERINGS CAN BE MADE ONLY IN ACCORDANCE WITH THE TERMS AND CONDITIONS SET FORTH IN THE INVESTMENT'S PRIVATE PLACEMENT MEMORANDUM. PRIOR TO INVESTING, INVESTORS ARE STRONGLY URGED TO REVIEW CAREFULLY THE PRIVATE PLACEMENT MEMORANDUM (INCLUDING THE RISK FACTORS DESCRIBED THEREIN), THE LIMITED PARTNERSHIP AGREEMENT AND THE SUBSCRIPTION DOCUMENTS, TO ASK SUCH QUESTIONS OF THE INVESTMENT MANAGER AS THEY DEEM APPROPRIATE, AND TO DISCUSS ANY PROSPECTIVE INVESTMENT IN THE FUND WITH THEIR LEGAL AND TAX ADVISERS IN ORDER TO MAKE AN INDEPENDENT DETERMINATION OF THE SUITABILITY AND CONSEQUENCES OF AN INVESTMENT.